DV Biomed Co., Ltd.

NT$36.20As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6539Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (13.69%)
Div yield 5.52%
ROE 14.97%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.11
PE TTM 11.51
TSR TTM (31.59%)
Mkt cap NT$881.4M
ROIC 26.09%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$35
(2.96%)
(47.67%)
Buy 10|11|1|1|2
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.63
0.71
0.71
0.70
29.99%
30.68%
20.07%
18.61%
RevenueNT$M
43.47
45.81
47.98
48.76
4.23%
6.76%
11.85%
13.85%
Peers (US$25.59M)
Cap (US$)
PE
23.68M
160.9x
Capital
TTM
5Y
10Y
Leveragex
0.449
0.387
0.374
EBIT/Intx
0.349
0.135
0.123
Own earn%
(62.99)
169.91
145.97
Sh yield%
24.46
55.79
55.42
Owners
Insiders/Inst%
5.67
31.31
Short interest%
2.87
SBC / revenue%
1.60
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
7–14
$1 testx
—
Incr. ROIC%
5